EIF3EP1

Across TCGA pan-cancer cohorts, EIF3EP1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated EIF3EP1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher EIF3EP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated EIF3EP1 expression acts as an unfavorable survival marker, although some lineages such as CESC and LUAD show a favorable association.

STAD, KICH, and ACC are the cancer types where EIF3EP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	II,III,IV	0.439	0.663	<.001	130	view →
KICH	DFS	Quartile	All	0.537	1.000	.001	55	view →
ACC	OS	Median	All	0.411	0.937	<.001	49	view →
CESC	OS	Tertile	All	0.942	0.838	.004	40	view →
LUAD	DFS	Tertile	III,IV	0.869	0.548	.005	37	view →
SKCM	DFS	Quartile	All	0.231	0.119	<.001	35	view →
MESO	DFS	Median	IV	0.192	0.466	.006	22	view →
LIHC	OS	Quartile	II,III,IV	0.390	0.726	.001	22	view →
KIRC	DFS	Median	IV	0.482	0.762	.019	14	view →
THYM	DFS	Tertile	III,IV	1.000	0.213	.004	12	view →
ESCA	OS	Median	All	1.000	0.670	.026	12	view →
GBM	DFS	Quartile	All	0.359	0.210	.013	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

EIF3EP1–STAD (DFS)

Open the STAD breakdown →